Halozyme Therapeutics
HALO
#2516
Rank
$5.47 B
Marketcap
$43.00
Share price
-1.87%
Change (1 day)
29.52%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of March 2024 : $0.46 B

According to Halozyme Therapeutics's latest financial reports the company has $0.46 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.33 B-7.39%
2022-12-31$0.36 B-51.03%
2021-12-31$0.74 B101.33%
2020-12-31$0.36 B-12.64%
2019-12-31$0.42 B18.82%
2018-12-31$0.35 B-24.44%
2017-12-31$0.46 B128.91%
2016-12-31$0.20 B89.2%
2015-12-31$0.10 B-20.12%
2014-12-31$0.13 B89.67%
2013-12-31$71.5 M-28.14%
2012-12-31$99.5 M88.36%
2011-12-31$52.82 M-36.55%
2010-12-31$83.25 M23.41%
2009-12-31$67.46 M5.88%
2008-12-31$63.71 M-34.77%
2007-12-31$97.67 M121.05%
2006-12-31$44.18 M130.97%
2005-12-31$19.13 M19.52%
2004-12-31$16 M3078.78%
2003-12-31$0.5 M417.83%
2002-12-31$0.09 M272.22%
2001-12-31$0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$26.21 B 5,557.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.92 B 2,473.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.58 B 458.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.92 B 2,042.22%๐Ÿ‡ซ๐Ÿ‡ท France
$3.02 B 552.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.30 B-35.11%๐Ÿ‡บ๐Ÿ‡ธ USA